Global Call for Collaborators – Pfizer Migraine Research
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Wednesday 6th, November 2024
External Deadline: Wednesday 13th, November 2024
Description
Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMGP competitive grant program involves a publicly posted general Call for Collaborator(s) (CFC(s)) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific CFC.
Date CFC Issued: October 2, 2024
Geographic Scope: Global
Clinical Area: Migraine
Link to full CFC: Global Call for Collaborators – Pfizer Migraine Research
Application Due Date: November 13, 2024
Specific Area of Interest: The intent of this CFC is to identify investigators with innovative research ideas who want to partner and co-develop research studies with Pfizer, and potentially other investigators where multiple proposals share similar objectives and methodological approaches.
Refer to complete details in the full CFC document. If you have questions regarding this CFC, please direct them in writing to the Grant Officer, Sue Lee (sue.lee@pfizer.com).